Experimental CAR-T Therapy Puts 3-Year-Old's Metastatic Liver Cancer Into Remission

In the long human struggle against cancer, few chapters carry the weight of a child's diagnosis — and few moments offer the quiet wonder of an unexpected remission. A three-year-old boy with metastatic liver cancer has entered remission after receiving just two doses of CAR-T immunotherapy, a treatment that reprograms the patient's own immune cells to seek and destroy cancer. The case, remarkable for the patient's age and the severity of his disease, suggests that the body's own defenses, when carefully guided by science, may reach where conventional medicine cannot. It is a single story, stil